|
1
|
El-Andari R, Bozso SJ, Kang JJH, Bedard
AMA, Adams C, Wang W and Nagendran J: Heart valve surgery and the
obesity paradox: A systematic review. Clin Obes.
12(e12506)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Moreira JL, Barletta PHAAS and Baucia JA:
Morbidity and Mortality in Patients Undergoing Mitral Valve
Replacement at a Cardiovascular Surgery Referral Service: A
Retrospective Analysis. Braz J Cardiovasc Surg. 36:183–191.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kumar RK, Antunes MJ, Beaton A, Mirabel M,
Nkomo VT, Okello E, Regmi PR, Reményi B, Sliwa-Hähnle K, Zühlke LJ,
et al: Contemporary diagnosis and management of rheumatic heart
disease: Implications for closing the gap: A scientific statement
from the American heart association. Circulation. 142:e337–e357.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sun JC, Davidson MJ, Lamy A and Eikelboom
JW: Antithrombotic management of patients with prosthetic heart
valves: Current evidence and future trends. Lancet. 374:565–576.
2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tsao CW, Aday AW, Almarzooq ZI, Alonso A,
Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP,
Commodore-Mensah Y, et al: Heart disease and stroke statistics-2022
update: A report from the American heart association. Circulation.
145:e153–e639. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wardrop D and Keeling D: The story of the
discovery of heparin and warfarin. Br J Haematol. 141:757–763.
2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Khoshnam-Rad N and Kargar M: Is
warfarin-induced rapid rise in INR post-cardiac surgery sssociated
with increased bleeding risk? Ann Pharmacother. 55:135–136.
2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang CL, Wu VC, Kuo CF, Chu PH, Tseng HJ,
Wen MS and Chang SH: Efficacy and safety of non-vitamin K
antagonist oral anticoagulants in atrial fibrillation patients with
impaired liver function: A retrospective cohort study. J Am Heart
Assoc. 7(e009263)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhu Z, Li Y, Meng X, Han J, Li Y, Liu K,
Shen J, Qin Y and Zhang H: New warfarin anticoagulation management
model after heart valve surgery: Rationale and design of a
prospective, multicentre, randomised trial to compare an
internet-based warfarin anticoagulation management model with the
traditional warfarin management model. BMJ Open.
9(e032949)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Byambajav T, Waki T, Miura K and
Tanaka-Mizuno S: Association between adherence to warfarin and
thrombotic events in patients with antiphospholipid syndrome in
Japan: A claims-based retrospective cohort study. Pharmacoepidemiol
Drug Saf. 31:149–157. 2022.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Kohsaka S, Katada J, Saito K, Jenkins A,
Li B, Mardekian J and Terayama Y: Safety and effectiveness of
non-vitamin K oral anticoagulants versus warfarin in real-world
patients with non-valvular atrial fibrillation: A retrospective
analysis of contemporary Japanese administrative claims data. Open
Heart. 7(e001232)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Soyombo BM, Taylor A, Gillard C, Wilson C
and Bailey Wheeler J: Impact of body mass index on 90-day warfarin
requirements: A retrospective chart review. Ther Adv Cardiovasc
Dis. 15(17539447211012803)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jiang S, Lv M, Zeng Z, Fang Z, Chen M,
Qian J, Wu T, Chen W and Zhang J: Efficacy and safety of app-based
remote warfarin management during COVID-19-related lockdown: A
retrospective cohort study. J Thromb Thrombolysis. 54:20–28.
2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bixby AL, Shaikh SA, Naik AS, Cotiguala L,
McMurry K, Samaniego-Picota MD, Marshall VD and Park JM: Safety and
efficacy of direct-acting oral anticoagulants versus warfarin in
kidney transplant recipients: A retrospective single-center cohort
study. Transpl Int. 33:740–751. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wong CS, Batchelor K, Bua J and Newall F:
Safety and efficacy of warfarin in paediatric patients with
prosthetic cardiac valves: A retrospective audit. Thromb Res.
128:331–334. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pritchard ER, Murillo JR Jr, Putney D and
Hobaugh EC: Single-center, retrospective evaluation of safety and
efficacy of direct oral anticoagulants versus low-molecular-weight
heparin and vitamin K antagonist in patients with cancer. J Oncol
Pharm Pract. 25:52–59. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jones K, Pham C, Aguilar C and Sheth S:
Retrospective review on the safety and efficacy of direct oral
anticoagulants compared with warfarin in patients with cirrhosis.
Fed Pract. 37:479–485. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Yang W, Ma J, Hu W, Dai H and Xu H:
Associated factors and safety of the rapidly achieving first
therapeutic target of warfarin in hospitalized patients: A
retrospective cohort study. Int J Clin Pharm. 44:939–946.
2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Margolis AR, Porter AL, Staresinic CE and
Ray CA: Impact of an extended International Normalized Ratio
follow-up interval on healthcare use among veteran patients on
stable warfarin doses. Am J Health Syst Pharm. 76:1848–1852.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sridharan K, Banny RA and Husain A:
Evaluation of stable doses of warfarin in a patient cohort. Drug
Res (Stuttg). 70:570–575. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ohshima A, Koyama T, Ogawa A, Zamami Y,
Tanaka HY, Kitamura Y, Sendo T, Hinotsu S, Miller MW and Kano MR:
Oral anticoagulants usage in Japanese patients aged 18-74 years
with non-valvular atrial fibrillation: A retrospective analysis
based on insurance claims data. Fam Pract. 36:685–692.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Maslin B, Springer E, Zhu R, Kodumudi V
and Vadivelu N: Perioperative Safety of Warfarin Therapy and
Reversal. Curr Drug Saf. 11:149–155. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lip GYH, Keshishian A, Kang A, Luo X,
Atreja N, Zhang Y, Schuler P, Jiang J, Yuce H and Deitelzweig S:
Effectiveness and safety of oral anticoagulants in non-valvular
atrial fibrillation patients with prior bleeding events: A
retrospective analysis of administrative claims databases. J Thromb
Thrombolysis. 54:33–46. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pilotto A, Gallina P, Copetti M, Pilotto
A, Marcato F, Mello AM, Simonato M, Logroscino G, Padovani A,
Ferrucci L, et al: Warfarin treatment and all-cause mortality in
community-dwelling older adults with atrial fibrillation: A
retrospective observational study. J Am Geriatr Soc. 64:1416–1424.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li Y, Liu W, Liu X, Shen H, Hou F, Jin P,
Xi Z and Zhou Y: Warfarin therapy in Chinese patients with atrial
fibrillation treated with percutaneous coronary intervention: A 5
year follow-up retrospective cohort study. Curr Med Res Opin.
35:1777–1783. 2019.PubMed/NCBI View Article : Google Scholar
|
